Navigation Links
Summa Health System Creates Quick Win With Their Caregiver Community By Implementing Sentillion's Clinical Workstation Solution
Date:7/30/2009

and securely authenticated and, through the power of SSO, the caregiver is automatically signed into Summa Health Systems' health information systems, which includes Eclipsys, SoftMed, OptiLink, Teletracking and AGFA. Additionally, the need to search for patients in multiple applications is eliminated since context management automatically tunes the applications to the selected patient's identity, saving time, and eliminating the potential for errors.

"At the time of go-live, each clinician participated in a five minute enrollment for single sign-on, along with a brief one-on-one review session," said Pam Banchy, System Director of Clinical Information Systems for Summa Health System. "Based on enhancements to their workflow and ease of use, clinician's identified additional future applications to add to SSO that would continue to improve quality of care delivery."

About Summa Health System

Summa Health System is one of the largest integrated delivery systems in Ohio. Encompassing a network of hospitals, community health centers, a health plan, a physician-hospital organization, a multi-specialty physician organization, research and multiple foundations, Summa is nationally renowned for excellence in patient care and for exceptional approaches to healthcare delivery. Summa's clinical services are consistently recognized by U.S. News and World Report, Thomson Reuters and The Leapfrog Group. Summa also is a founding partner of the BioInnovation Institute in Akron. For more information, visit www.summahealth.org.

About Sentillion

Since 1998, Sentillion has been revolutionizing healthcare IT with award winning, industry recognized identity and access management technology. Sentillion has successfully combined patented technology with a deep understanding of the healthcare industry to deliver the most comprehensive set of solutions for single sign-on, identity man
'/>"/>

SOURCE Sentillion
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2 3

Related medicine news :

1. Econiche(TM) Vaccine Efficacy Summarized in July Issue of Foodborne Pathogens and Disease
2. Connectyx Technologies Holdings Groups CEO Gives Shareholders a Summary of Events for First Half of 2009 and Announces Teleconference Call on July 9th to Discuss Future Strategy
3. New book summarizes current knowledge on the biology of the vertebrate skeleton
4. Summa Health System Performs Northeast Ohios First Robotic Lobectomy
5. SummaCare Selects Burgess Software As Its Comprehensive Medicare Pricing Solution
6. Summa Health Network Announces Contract with MDdatacor to Support Multi-Insurer Health Care Quality Initiative; Initiative to Use Clinical Data to Supplement Claims Data and Enhance Outcomes
7. Health Book Summaries Subscriber Base Grows to 60,000 Readers as Health Consumers Applaud Free Format
8. Summary Judgment Granted for SEROQUEL(R) Patent Litigation
9. Alijor.com Now Offers Price Summaries for Healthcare Services in Major U.S. Cities
10. Caraco Pharmaceutical Laboratories Ltd. Wins Summary Judgment on Generic Ultracet(R)
11. DARA BioSciences, Inc. and Point Therapeutics, Inc. Announce Consummation of Merger

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/20/2009)... The American Academy o... care reform legislation released this week to con...e individual coverage mandate. The actuaries said ...imize adverse selection stemming from more restric.... ,, "The individual mandate language should be...
(Date:11/20/2009)...s and Congressmen in Competitive Re-election Battl... , Washington, DC (Vocus)...ning for re-election next year in races deemed to ... come to regret voting for House Speaker Nancy Pel...ing Zogby International/ O’Leary Report pol...
(Date:11/20/2009)... Centene Corporation (N...at the Bank of America Merrill Lynch 2009 Credit C...rowne Plaza Hotel Times Square in New York City. ,...at 8:30 a.m. Eastern Time. Investors and other int...f Centene,s presentation at: http://www.veracast....
(Date:11/20/2009)...ewswire-USNewswire/ -- The following is a statemen...da Health Care Association: ,, "The Nevada Heal...ate Majority Leader Harry Reid for his leadership ... of protecting every Nevada seniors, ongoing acces... strength and viability of our state,s vital front...
(Date:11/20/2009)...ormaldehyde used for embalming in the funeral indu...th from myeloid leukemia, according to a new study...he National Cancer Institute . , Previous studie...etic malignancies and brain cancer in anatomists, ... whom may have worked with formaldehyde. , For...
Breaking Medicine News(10 mins):Health News:Actuaries to Senate: Strengthen Individual Mandate 2Health News:Just 25% of Voters in Competitive 2010 Senate Races “Much More Likely” to Support Pelosi-Democrats Who Voted for Health Care Bill 2Health News:Just 25% of Voters in Competitive 2010 Senate Races “Much More Likely” to Support Pelosi-Democrats Who Voted for Health Care Bill 3Health News:Funeral industry workers exposed to formaldehyde face higher risk of leukemia 2
...n,(Nasdaq: MDTH ), a healthcare provider focused ...the diagnosis and treatment of cardiovascular,dise... first fiscal,quarter, which ended December 31, 20...). As part of the,recapitalization, MedCath,s owne...
...ploying,cross- functional, yet sufficiently specia...g leaders at pharmas and biotechs. However,best-in... similar,structure, composition, and responsibilit...have a core team of three,to 10 people and 86 perc...
...RAXIS Health Inc. (TSX:,DAX); (Nasdaq: DRAX ) rep...,the year ended December 31, 2007. Results for the...rter of 2006 were impacted by lower product sales,...th quarter of 2007 relative to the same quarter in...
...) Research Proves Dance Dance Revolut... Feb. 7 Based on the growing popularity of,video ... in favor of more,full-body interaction, the Ameri...sse, focused on quantifying DDR,s potential physic...
...asdaq: NUVO ) today announced that it will hold t...estor Conference February 13, 2008 11:45 a.m. ...ww.corporate-ir.net/ireye/conflobby.zhtml?ticker=N... ET (1:30 p.m. PT) Dr. Ted W. Love, Chairman and ...
...r and Health Advocates Together to Educate Co...SOUTHBOROUGH, Mass., Feb. 7 Most Americans are aw...id you know the Environmental,Protection Agency sa... out of 10 Americans are unaware of this fact,prim...
Other Medicine News:Health News:MedCath Corporation Reports First Quarter Earnings 2Health News:MedCath Corporation Reports First Quarter Earnings 3Health News:MedCath Corporation Reports First Quarter Earnings 4Health News:MedCath Corporation Reports First Quarter Earnings 5Health News:MedCath Corporation Reports First Quarter Earnings 6Health News:MedCath Corporation Reports First Quarter Earnings 7Health News:MedCath Corporation Reports First Quarter Earnings 8Health News:MedCath Corporation Reports First Quarter Earnings 9Health News:MedCath Corporation Reports First Quarter Earnings 10Health News:MedCath Corporation Reports First Quarter Earnings 11Health News:MedCath Corporation Reports First Quarter Earnings 12Health News:Pharmaceutical Product Commercialization & Governance Best Practices: Securing Talent for Highly-Effective Brand Teams 2Health News:DRAXIS Health Reports Fourth Quarter and Year End Results 2Health News:DRAXIS Health Reports Fourth Quarter and Year End Results 3Health News:DRAXIS Health Reports Fourth Quarter and Year End Results 4Health News:DRAXIS Health Reports Fourth Quarter and Year End Results 5Health News:DRAXIS Health Reports Fourth Quarter and Year End Results 6Health News:DRAXIS Health Reports Fourth Quarter and Year End Results 7Health News:DRAXIS Health Reports Fourth Quarter and Year End Results 8Health News:DRAXIS Health Reports Fourth Quarter and Year End Results 9Health News:DRAXIS Health Reports Fourth Quarter and Year End Results 10Health News:DRAXIS Health Reports Fourth Quarter and Year End Results 11Health News:DRAXIS Health Reports Fourth Quarter and Year End Results 12Health News:DRAXIS Health Reports Fourth Quarter and Year End Results 13Health News:DRAXIS Health Reports Fourth Quarter and Year End Results 14Health News:DRAXIS Health Reports Fourth Quarter and Year End Results 15Health News:DRAXIS Health Reports Fourth Quarter and Year End Results 16Health News:DRAXIS Health Reports Fourth Quarter and Year End Results 17Health News:DRAXIS Health Reports Fourth Quarter and Year End Results 18Health News:DRAXIS Health Reports Fourth Quarter and Year End Results 19Health News:DRAXIS Health Reports Fourth Quarter and Year End Results 20Health News:DRAXIS Health Reports Fourth Quarter and Year End Results 21Health News:DRAXIS Health Reports Fourth Quarter and Year End Results 22Health News:DRAXIS Health Reports Fourth Quarter and Year End Results 23Health News:DRAXIS Health Reports Fourth Quarter and Year End Results 24
(Date:11/20/2009)... , PLYMOUTH MEETING, Pa., Nov. 20 /PRNewswir... Times article that questions why currently avail...e cancers are being ignored, ECRI Institute, an in...admap to the evidence on Finasteride for Preventi...The November 13, 2009, New York Times article, "...
(Date:11/20/2009)..., MEMPHIS, Tenn., Nov. 20 /PRNewswire-FirstCa...dics Division is pleased to announce the signing o...d States Department of Defense that may lead to th...to revolutionize the treatment of the limbs of sol... year, the Defense Advanced Research Projects Agen...
(Date:11/19/2009)... , ARDEE, Ireland, Nov. 19 War...the pricing of its previously announced secondary ... price to the public of $22.25 per share. The sel...in Capital Partners, DLJ Merchant Banking, J.P. Mo... H. Lee Partners, L.P., certain other institutiona...
Breaking Medicine Technology:ECRI Institute Releases Roadmap to the Evidence on Finasteride for Prevention of Prostate Cancer: New Hotline Report to Aid Healthcare Decision Makers and Journalists 2ECRI Institute Releases Roadmap to the Evidence on Finasteride for Prevention of Prostate Cancer: New Hotline Report to Aid Healthcare Decision Makers and Journalists 3Smith & Nephew Orthopaedics Selected to Develop New Technology for Treating Battlefield Injuries 2Smith & Nephew Orthopaedics Selected to Develop New Technology for Treating Battlefield Injuries 3Smith & Nephew Orthopaedics Selected to Develop New Technology for Treating Battlefield Injuries 4Warner Chilcott Prices Secondary Equity Offering 2Warner Chilcott Prices Secondary Equity Offering 3Warner Chilcott Prices Secondary Equity Offering 4CEM Wins Presidential Green Chemistry Challenge Award for the Sprint Rapid Protein Analyzer 12724 1CEM Wins Presidential Green Chemistry Challenge Award for the Sprint Rapid Protein Analyzer 12724 2KV Pharmaceutical Receives Letter From NYSE Regarding Delayed Filing of Its 2009 Annual Report on Form 10 K 49600 1KV Pharmaceutical Receives Letter From NYSE Regarding Delayed Filing of Its 2009 Annual Report on Form 10 K 49600 2KV Pharmaceutical Receives Letter From NYSE Regarding Delayed Filing of Its 2009 Annual Report on Form 10 K 49600 3KV Pharmaceutical Receives Letter From NYSE Regarding Delayed Filing of Its 2009 Annual Report on Form 10 K 49600 4KV Pharmaceutical Receives Letter From NYSE Regarding Delayed Filing of Its 2009 Annual Report on Form 10 K 49600 5KV Pharmaceutical Receives Letter From NYSE Regarding Delayed Filing of Its 2009 Annual Report on Form 10 K 49600 6 New Strategy Eyed for AIDS Treatment 49598 1 New Strategy Eyed for AIDS Treatment 49598 2
...itor, and R7128, nucleoside polymerase inhibitor, ...n patients with hepatitis C - , , NUTLEY, N.J., ...oche, InterMune, Inc. (Nasdaq: ITMN ) and Pharma...esults from their innovative, interferon-free regi...herapy for the treatment of patients chronically i...
...rmed to date will be presented during the Internat...nnual Meeting in Paris, France on April 24, 2009 ...d as an in vitro assessment of cell-mediated imm...erous clinical investigations have contributed to ...g recipients of solid organ transplants. , , (Lo...
Other Medicine Technology:Ground-Breaking Combination of All-Oral Agents Demonstrates Potential as Hepatitis C Treatment Regimen 2Ground-Breaking Combination of All-Oral Agents Demonstrates Potential as Hepatitis C Treatment Regimen 3Ground-Breaking Combination of All-Oral Agents Demonstrates Potential as Hepatitis C Treatment Regimen 4Ground-Breaking Combination of All-Oral Agents Demonstrates Potential as Hepatitis C Treatment Regimen 5Ground-Breaking Combination of All-Oral Agents Demonstrates Potential as Hepatitis C Treatment Regimen 6Ground-Breaking Combination of All-Oral Agents Demonstrates Potential as Hepatitis C Treatment Regimen 7Ground-Breaking Combination of All-Oral Agents Demonstrates Potential as Hepatitis C Treatment Regimen 8Ground-Breaking Combination of All-Oral Agents Demonstrates Potential as Hepatitis C Treatment Regimen 9Ground-Breaking Combination of All-Oral Agents Demonstrates Potential as Hepatitis C Treatment Regimen 10Ground-Breaking Combination of All-Oral Agents Demonstrates Potential as Hepatitis C Treatment Regimen 11An Independent Study Reports on the Utility of ImmuKnow(R), the Cylex(TM) Immune Cell Function Assay, for Monitoring Heart Transplant Recipients 2
Bipolar Bayonet Forceps
Elmed Extra Long Straight Bipolar Forceps
Micro Forceps
Bi-Co-Matic Handswitching Bipolar Micro Forceps with Elmed Fitting, Insulated
Medicine Products: